Mobile Platform for Optimizing Wellness and Engagement in Recovery (MPOWER)

University of Michigan

Status: Enrolling

Conditions: Opioid Use Disorder; Opioid Agonist Treatment; Alcohol Use Disorder

Treatments: Behavioral: Digital Contingency Management Intervention Arm; Behavioral: Digital Wellness Arm

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT07178990

HUM00266546

1R34AA031870-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Enrollment: 50 estimated patients

Sex: All

Ages: 19 to 63 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants must be enrolled in the Michigan Medicaid program
• Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
• Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
• Participants must have regular access to a working smartphone and internet connection.
• Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion criteria

• Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
• Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
• Individuals with substantial cognitive impairment that would interfere with study participation
• Individuals unable to read or understand English
• Individuals experiencing active suicidality or psychosis.
• Individuals with a planned admission to residential treatment or incarceration during the study period.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Digital Contingency Management (CM) Intervention Arm

Experimental group

Description:

After participants meet eligibility and complete the DynamiCare assessment period, participants randomized to this group will receive a comprehensive digital CM platform designed to enhance OAT retention and promote abstinence from alcohol and opioids. This will include the DynamiCare Motivation Support Program.

Treatment:

Behavioral: Digital Contingency Management Intervention Arm

Wellness Condition

Active Comparator group

Description:

After participants meet eligibility and complete the DynamiCare assessment period, those randomized to this group will receive a wellness digital platform that includes surveys, testing, and tech support.

Treatment:

Behavioral: Digital Wellness Arm